Patients who achieved HIV virologic suppression tended to be older and were more likely to report continued engagement in HIV care than those with persistent viremia.

Hetero and Dr Reddy’s — will be funded by the Gates Foundation and Unitaid, respectively, to produce and sell the twice-a-year anti-HIV shot, lenacapavir, for $40 (around R692) per person per ...

While the tests can make it easier for people to access health care and can be helpful for those who have extreme anxiety ...

USAID antimalarial and HIV supplies valued at nearly $140 million were delayed in the first half of the year or not delivered ...

Drug can be used to prevent catching the virus and treat those who have it Kampala, Uganda | THE INDEPENDENT & AGENCIES | A ...

According to the World Health Organization (WHO), lenacapavir offers a highly effective, long-acting alternative to daily ...

Nearly nine years ago, when Emma Walmsley was preparing to take over as CEO of GSK Plc, she wrote in her diary that Luke ...

October is National Substance Abuse Prevention Month, an opportunity to recognize the impact of substance use in the U.S. and ...

Year's supply of injectable to cost Rs 3,549, compared to over Rs 17 lakh in US. Powerful alternative to daily oral PrEP, ...

In his first term, President Trump pledged to boost HIV spending, with the lofty goal of bringing the epidemic to heel by ...

GSK plc names new CEO as shares rise 3% and maintains a 4% dividend yield; get key insights on GSK stock's outlook and what ...